To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults | MicrobiomeTrials← Back to trialsNCT07655960
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-11Est. Completion: 2026-06-26
Enrollment target: 41 participants Locations- H+ Yangji Hospital, Seoul, Republic of South Korea, Seoul, South Korea
Other microbiome trials you might be interested in
HypercholesterolemiaAtherosclerosis
This study will evaluate people with dyslipidemias - disorders that affect the fat content in the blood. Fats, or lipids…
Bethesda, United States
Hypercholesterolemia
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholes…
Seoul, South KoreaCompleted Jul 10, 2025